Malignant Melanoma
Showing NaN - NaN of 21
Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)
Active, not recruiting
- Malignant Melanoma
- Pembrolizumab
- +2 more
-
Los Angeles, California
- +118 more
Aug 22, 2022
Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)
Recruiting
- Malignant Melanoma
- UV1
- +3 more
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)
Recruiting
- Malignant Melanoma
- Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
-
Aurora, ColoradoUniversity of Colorado Hospital
May 25, 2022
Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)
NSCLC, Urothelial Carcinoma, Malignant Melanoma Trial in Aurora, Lake Mary, Philadelphia (CAN04, Pembrolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +3 more
-
Aurora, Colorado
- +2 more
Nov 17, 2020
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +111 more
Oct 16, 2019
Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)
Completed
- Malignant Melanoma
-
Los Angeles, California
- +9 more
Jul 26, 2019
Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +110 more
Aug 19, 2016
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +79 more
Jun 23, 2005
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +76 more
Jun 23, 2005